Results 231 to 240 of about 41,600 (260)
Some of the next articles are maybe not open access.

Effect of dipeptidyl peptidase‐4 inhibitors on complement activation

Diabetes/Metabolism Research and Reviews, 2020
AbstractBackgroundAdverse activation of the complement cascade in the innate immune system appears to be involved in development of vascular complications in diabetes. Dipeptidyl peptidase‐4 (DPP‐4) is a cell surface serine protease expressed in a variety of tissues.
Ingeborg T. Hoffmann‐Petersen   +7 more
openaire   +3 more sources

Renal outcomes with dipeptidyl peptidase-4 inhibitors

Diabetes & Metabolism, 2018
Dipeptidyl peptidase-4 inhibitors (DPP-4is) are increasingly being used in the management of type 2 diabetes (T2D). The present review summarizes the current knowledge of the effects of DPP-4is on renal outcomes by analyzing the experimental preclinical data, the effects of DPP-4is on urinary albumin-creatinine ratios (UACRs) and estimated glomerular ...
Scheen, André, DELANAYE, Pierre
openaire   +3 more sources

Dipeptidyl peptidase-4 inhibition and renoprotection

Current Opinion in Nephrology and Hypertension, 2017
This article analyzes the potential beneficial effects of dipeptidyl peptidase (DPP)-4 inhibitors on renal diseases.The pathological significance of DPP-4, either dependent or independent on catalytic activities, on renal diseases has been reported in preclinical studies.
Yuta, Takagaki   +2 more
openaire   +2 more sources

Dipeptidyl peptidase-4 inhibitors

2016
Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.
openaire   +1 more source

Periostin and Dipeptidyl Peptidase-4

Immunology and Allergy Clinics of North America, 2018
Claire Emson   +3 more
openaire   +1 more source

Dipeptidyl Peptidase-4 – A Comprehensive Review

Current Enzyme Inhibition
Type 2 diabetes mellitus is a growing global public health issue, with its prevalence projected to increase in the coming decades. It is one of the most prevalent and growing global health concerns, affecting millions of individuals worldwide. The condition is classified into two primary types: Type 1 diabetes,
Venkatesan Parthasarathi   +1 more
openaire   +1 more source

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham   +2 more
openaire   +1 more source

Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review

International Journal of Molecular Sciences, 2019
Rui Liu, Hao Wu, Rui Liu
exaly  

DIPEPTIDYL PEPTIDASE-4 INHIBITOR

2011
TOMINAGA YUJI   +6 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy